Physician profile
Peter A Caravella
NPI 1497945232
$671,077.05
in general payments reported to CMS, 2019-2025
33 companies · $6,495 in 2025
The $6,495 reported for 2025 was more than what 86% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269K · 2020: $60K · 2021: $102K · 2022: $106K · 2023: $73K · 2024: $56K · 2025: $6,495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $84K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Travel and Lodging: $10K · Food and Beverage: $8,780 · Honoraria: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $84,425.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31,437.50 |
| Travel and Lodging | $10,317.46 |
| Food and Beverage | $8,779.53 |
| Honoraria | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $664,392.47 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Heron Therapeutics, INC. | $1,900.00 | 2020 | |
| Tela Bio, INC. | $666.70 | 2019-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $571.37 | 2021-2025 | Endurant Iis, Dextile, Progrip |
| Davol INC. | $495.82 | 2019-2024 | Phasix Mesh |
| Sirtex Medical INC | $436.79 | 2025 | Sir-Spheres Microspheres |
| Distalmotion US | $327.49 | 2025 | Dexter L6 Robot |
| Koya Medical, INC. | $325.86 | 2024 | Dayspring, Koya Medical |
| Sanara Medtech INC. | $272.16 | 2024-2025 | Celleraterx, Celleraterx, Biasurge |
| Inari Medical, INC. | $250.00 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Silk Road Medical, INC. | $182.75 | 2021 | |
| Boston Scientific Corporation | $153.20 | 2021-2025 | Varithena Administration Pack, Wavewriter Alpha Prime 16 |
| Globus Medical, INC. | $146.26 | 2025 | Alif |
| Shockwave Medical, INC | $103.70 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bard Peripheral Vascular, INC. | $99.04 | 2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endogastric Solutions, INC | $93.03 | 2021 | |
| Balt USA, LLC | $89.60 | 2025 | Prestige Coil System |
| W. L. Gore & Associates, INC. | $83.28 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $69.43 | 2019-2024 | Exparel |
| Conmed Corporation | $55.56 | 2019 | |
| Cardiovascular Systems INC. | $50.05 | 2019-2021 | |
| Ethicon US, LLC | $48.93 | 2023 | Echelon Flex, Mega Soft |
| Abbott Laboratories | $36.77 | 2019 | |
| Medtronic Vascular, INC. | $35.00 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.68 | 2024 | Gattex |
| Kerecis Limited | $29.18 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Covidien LP | $24.14 | 2019-2020 | |
| Lemaitre Vascular, INC. | $22.13 | 2019 | |
| Endologix LLC | $18.08 | 2025 | Alto Abdominal Stent Graft System |
| Avanos Medical | $18.06 | 2019 | |
| Biom'Up France Sas | $18.03 | 2020 | |
| Hologic INC | $17.43 | 2022 | |
| Angiodynamics, INC. | $15.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Caravella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.